National HealthCare Corporation
NHC · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.31 | 0.11 | -0.49 | 0.03 |
| FCF Yield | 4.81% | 5.89% | -2.34% | 2.21% |
| EV / EBITDA | 9.83 | 10.69 | 14.41 | 5.75 |
| Quality | ||||
| ROIC | 4.72% | 3.63% | 2.04% | 3.92% |
| Gross Margin | 37.52% | 37.60% | 36.13% | 34.11% |
| Cash Conversion Ratio | 1.05 | 1.70 | 0.44 | 0.45 |
| Growth | ||||
| Revenue 3-Year CAGR | 6.51% | 4.13% | 3.08% | 0.48% |
| Free Cash Flow Growth | -4.34% | 488.27% | -193.32% | -87.32% |
| Safety | ||||
| Net Debt / EBITDA | 0.76 | -0.10 | 0.99 | 0.31 |
| Interest Coverage | 20.74 | 176.34 | 56.65 | 60.27 |
| Efficiency | ||||
| Inventory Turnover | 89.71 | 96.45 | 96.81 | 77.61 |
| Cash Conversion Cycle | 30.79 | 28.82 | 28.82 | 27.25 |